NDC 0002-7772-11
EBGLYSS 250 mg/2mL
lebrikizumab-lbkz · INJECTION, SOLUTION
EBGLYSS is a injection, solution containing lebrikizumab-lbkz at a strength of 250 mg/2mL. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- EBGLYSS
- Generic Name
- lebrikizumab-lbkz
- NDC Code (Package)
0002-7772-11- NDC Code (Product)
0002-7772- Manufacturer
- Eli Lilly and Company
- Strength
- 250 mg/2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761306
- Drug Class
- Interleukin-13 Antagonist [EPC]
- Marketing Start
- 09/13/2024
Recall History
No Recall HistoryView Full Drug Page
EBGLYSS — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.